EGTTF yields 1052.63% · JNJ yields 2.13%● Live data
📍 EGTTF pulled ahead of the other in Year 1
Combined, EGTTF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of EGTTF + JNJ for your $10,000?
EYEFI Group Technologies Inc., an electronics and software engineering company, develops spatial, predictive, approximation, and radial convolution (SPARC) technology. Its products include EYEfi Cloud, a platform that offers remote monitoring, intelligence gathering, and situational awareness solutions; EYEfi Sensors, which is used for monitoring and intelligence gathering applications from industrial-grade camera sensors; EYEfi SPARC, a situational awareness technology for government and industry; and EYEfi SPARC (mobile), a solution that spatially enables smartphones, wearable technology, and UAVs. The company's SPARC solution turns sensors, cameras, or smartphone devices (fixed, mobile, airborne, portable, or handheld) into target co-ordinate acquisition systems. Its solutions also include Industrial Internet of Things (IIoT) hardware sensor product and cloud application (Smart Waste) for waste bins and smart drain for storm water pits. The company, through resellers, serves government and industry customers in the infrastructure and asset management, emergency management, and incident response markets primarily in Australia and New Zealand. EYEFI Group Technologies Inc. was incorporated in 2018 and is headquartered in Collingwood, Australia.
Full EGTTF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.